Key result
ACE gene I/D and PstI polymorphisms showed no significant association with the development of nephropathy in patients with non-insulin dependent diabetes mellitus.
Why the study?
Is there an association between ACE gene I/D and PstI polymorphisms and the development of nephropathy in patients with NIDDM?
Case-Control (n=941)
Is there an association between ACE gene I/D and PstI polymorphisms and the development of nephropathy in patients with NIDDM?
This study suggests that there is no significant association between the ACE gene I/D and PstI polymorphisms and the susceptibility to diabetic nephropathy in patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
No association seen in this case-control study; leaves open ACE polymorphism contributions to diabetic nephropathy and requires larger prospective confirmation.
Nephropathy is a frequent complication of long-term diabetes. Strong evidence exists that genetic predisposition plays a major role in the development of diabetic nephropathy. The role of the angiotensin I-converting enzyme gene (ACE) in the susceptibility to nephropathy in diabetes, especially in non-insulin dependent diabetes mellitus (NIDDM), remains unclear. This study examines the association of two ACE polymorphisms: a 287-bp insertion/deletion (I/D) in intron 16 and PstI (A/G substitution in intron 7; alleles P/M) with renal complications in 941 NIDDM patients. From this group, for further analysis 127 patients were selected with overt proteinuria or chronic renal failure, 335 patients with microalbuminuria, and a control group of 254 normoalbuminuric patients with a diabetes duration of at least 10 yr. No significant differences in the distribution of ACE I/D and PstI genotypes or allele frequencies were observed between the examined groups. The results of this study strongly suggest that there is no association between the ACE gene I/D and PstI polymorphisms and nephropathy in NIDDM.
No takes yet. Share an insight, caveat, or question.
Grzeszczak et al. (1998) conducted a case-control in Non-insulin dependent diabetes mellitus (NIDDM) and nephropathy (n=941). ACE gene I/D and PstI polymorphisms vs. Normoalbuminuric NIDDM patients (controls) was evaluated on Distribution of ACE I/D and PstI genotypes or allele frequencies. ACE gene I/D and PstI polymorphisms showed no significant association with the development of nephropathy in patients with non-insulin dependent diabetes mellitus.
Synapse has enriched 10 related papers. Consider them for comparative context: